SCHEMBL211336

SCHEMBL211336

O=Cc1ccc(N2CCOCC2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.70
TRIM33 Q9UPN9 1/20 0.70
ALDH1A1 P00352 11/20 0.68
KDM4E B2RXH2 4/20 0.68
SMN1; SMN2 Q16637 4/20 0.68
ALDH3A1 P30838 1/20 0.59
ALDH1A3 P47895 1/20 0.59
PIK3CD O00329 1/20 0.57
PIK3CA P42336 1/20 0.57
PIK3CB P42338 1/20 0.57
PIK3CG P48736 1/20 0.57
PRKDC P78527 1/20 0.57
MITF O75030 1/20 0.57
TP53 P04637 2/20 0.56
HSD17B10 Q99714 2/20 0.56
HPGD P15428 1/20 0.56
MAPT P10636 7/20 0.54
MEN1 O00255 6/20 0.54
KMT2A Q03164 6/20 0.54
NPC1 O15118 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL881493 0.98 TRIM24 (0.68) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL12526120 0.98 TRIM24 (0.68) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL10070834 0.98 TRIM24 (0.68) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL22579249 0.94 TRIM24 (0.63) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL10070689 0.91 LMNA (0.69) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL2561698 0.87 TRIM24 (0.83) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3077544 0.87 TRIM24 (0.83) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL1688379 0.84 ALDH3A1 (0.56) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL7995794 0.83 L3MBTL3 (0.54) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL253732 0.83 TRIM24 (1.00) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1389 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025234971-A1 NEW MORPHOLINE SCHIF BASE AND THE USE THEREOF IN DISEASES CAUSED BY VIRAL PATHOGENS YEDITEPE UNIVERSITESI (TR) 2025-11-13 WO claimed
CN-119410005-A Preparation method of flexible room-temperature phosphorescent material 桂林理工大学 2025-02-11 CN claimed
CN-118638037-A Lysosome targeting pH and viscosity difunctional response probe and application thereof 遵义医科大学珠海校区 2024-09-13 CN claimed
CN-114656476-B Lysosome targeting rhodamine B hydrazide fluorescent probe as well as preparation method and application thereof 晋中学院 2024-08-30 CN claimed
US-11918671-B2 Multi-tone hair dyeing method in three steps HENKEL AG & CO. KGAA (DE) 2024-03-05 US claimed
CN-116102485-B Half cyanine analog ratio type fluorescent probe for detecting sulfur dioxide derivative and preparation method and application thereof 齐鲁工业大学 2024-02-27 CN claimed
CN-114436961-B Acid response fluorescent small molecule, preparation method and application thereof 吴江市汉塔纺织整理有限公司 2023-09-15 CN claimed
CN-116370645-A Endoplasmic reticulum targeted fluorescent nano-carrier, preparation method and application thereof 齐鲁工业大学(山东省科学院) 2023-07-04 CN claimed
CN-116102485-A Half cyanine analog ratio type fluorescent probe for detecting sulfur dioxide derivative and preparation method and application thereof 齐鲁工业大学 2023-05-12 CN claimed
CN-114436995-B Morpholine-indenone-chalcone derivative fluorescent probe and preparation method and application thereof 河南理工大学 2023-04-25 CN claimed
WO-2003030845-A1 AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO claimed
WO-2003030842-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO claimed
WO-2003030847-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO claimed
EP-1300132-A2 Agent for dyeing keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2003-04-09 EP claimed
EP-1300133-A2 Agent for dyeing keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2003-04-09 EP claimed
WO-2003024923-A1 SULFONAMIDE COMPOUNDS AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2003-03-27 WO claimed
EP-1200051-A1 AGENT FOR DYING KERATIN FIBERS Henkel Kommanditgesellschaft auf Aktien (DE) 2002-05-02 EP claimed
WO-2001013866-A1 AGENT FOR DYING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-03-01 WO claimed
US-4582903-A Synthesis of unsaturated hydantoins with an inexpensive catalyst STAUFFER CHEMICAL COMPANY (US) 1986-04-15 US claimed
US-4345072-A Process for the production of 5-arylidene hydantoins (B) DEGUSSA AG (DE) 1982-08-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11918671-B2 Multi-tone hair dyeing method in three steps TYR, HAO2, HAAO TRIM24 2169/4885TRIM33 1420/4885ALDH1A1 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.